Recall Record

Alameda, CA, United States

Abbott Diabetes Care, Inc. recalls

6 recalls recorded since 2018, most recently on 24 November 2025. 4 are listed as ongoing. Status and classification are as published by the FDA.

Recalls6
Ongoing (FDA)4
Terminated or completed2
Class I (FDA)3

Ongoing Class I Medical devices

Recall started
24 November 2025
Reason
Due to a manufacturing process issue that may cause carbon build up in the sensor that may result in incorrect low glucose results
Distribution
U.S.: AK, AL, AZ, CA, CO, FL, GA, IA, ID, IL, IN, KS, LA, MA, MD, MI, MN, MO, MS, MT, NC, NE, NJ, NV, NY, OH, OK, PA, SC, SD, TX, UT, VA, WI, WV, and WY. O.U.S.: Andorra, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Italy, Luxembourg, Netherlands, New Zealand, Norway, Qatar, San Mar
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1020-2026, Z-1021-2026, Z-1022-2026, Z-1023-2026

Ongoing Class I Medical devices

Recall started
24 July 2024
Reason
Users of the FreeStyle Libre 3 sensors reported situations where they were receiving erroneously high glucose results. The inaccurate higher glucose values may lead to users calculating higher insulin bolus correctional doses based on inaccurate CGM glucose data. The inaccurate higher glucose values may also contribute to missed or delayed recognition of hypoglycemia, when the sensor incorrectly reports normal or even high glucose values when the actual glucose is trending low or is low. If the hypoglycemia missed by the device occurs acutely, a user may not be able to confirm the actual glucose with a self-monitored blood glucose (BG) and/or administer prompt intervention to raise glucose levels. The over-delivery of insulin and/or the missed or delayed detection of impending or overt hypoglycemia in the worst-case scenario may lead to severe hypoglycemia/hypoglycemic crisis with significant adverse health consequences. Such consequences include central nervous system dysfunction, loss of consciousness, seizure activity and may lead to coma, permanent neurological damage, and death.
Distribution
US distribution to states of: NJ, PA, OH, TX, VA, CA, NY, FL, WA, MS, MN, and WY
Initiated
Voluntary: Firm initiated
Recall number
Z-2692-2024

Ongoing Class II Medical devices

Recall started
12 July 2023
Reason
If blood glucose monitoring system users attempt to start a new sensor, when the old sensor wasn't used for the full 14-day wear time, then the reader may display "Incompatible Sensor" message. If users don't have the previous sensor, or FreeStyle Libre 2 app, or the sensor's full wear time hasn't ended, users may be unable to start a new sensor, which could result in no or delayed glucose results
Distribution
US Nationwide distribution in the states of CA, FL, MI, NY, OH, TX, UT, VA.
Initiated
Voluntary: Firm initiated
Recall number
Z-2414-2023

Ongoing Class I Medical devices

Recall started
13 February 2023
Reason
Lithium-ion batteries in glucose monitoring system readers may swell, overheat, or pose fire hazard. Only use the charging cable/power adapter included with readers. Do not use reader if it is damaged, cracked, swelling, too hot to hold, it will no longer hold charge, or it fails Reader Test. Do not use other chargers. User Manual update includes instructions on reader safe storage, charging, use.
Distribution
U.S. Nationwide.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1275-2023, Z-1274-2023, Z-1273-2023

Completed Class II Medical devices

Recall started
9 February 2023
Reason
If using affected glucose monitoring app on Android 13 Operating System, extended periods of signal loss may be experienced, due to app not connected, which could impact ability to receive glucose reading/alarms, which could lead to undetected low or high glucose, which could result in delayed treatment: not taking insulin (for high glucose), or not taking glucose (for low glucose) when required.
Distribution
US Nationwide distribution in the states of NY, CA, NJ, UT, PA, MS, OH, TX, MN, FL, LA, NE, MI, VA, NC, MA, IN, SC, IA.
Initiated
Voluntary: Firm initiated
Recall number
Z-0734-2024

Terminated Class II Medical devices

Recall started
14 November 2019
Terminated
28 April 2021
Reason
Instructions sent in a letter or in instructions for use for disinfecting blood glucose and/or ketone meters were distributed but not cleared by the U.S. FDA, and devices were not cleared for multiple-patient use. Instructions could lead to inappropriate meter disinfection or improper handling of contaminated meters, which may cause infection or exacerbation of an existing infection.
Distribution
U.S.: KY, NY, TN, MA, IL, SC, VT, FL, CA, NC, MS, NJ, TX, AL, GA, OK, CT, PA, NE, ND, MT, MO, DC, ME, LA, KS, ID, OH, MN, NM, VA, IN
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1556-2020, Z-1557-2020, Z-1558-2020

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.